Page 84 - Read Online
P. 84

Maqboul et al. Mini-invasive Surg 2021;5:44  https://dx.doi.org/10.20517/2574-1225.2021.54  Page 17 of 19

               postoperative period, but the surgery was not performed robotically. There are a number of studies
               examining ERAS in RARC, but only a small number of these include RIN, and although it is perceptively
                                                                     [7]
               that the combination would be beneficial, more study is required .

               CONCLUSION
               There has been slow adoption of RARC with RIN in specialized centers for the treatment of high-risk and
               muscle-invasive bladder cancer. Although it is a challenging technique, it represents a natural evolution of
               the minimally invasive approach with robotics. The technique has a steep LC and longer OTs as a result and
               many potential advantages, such as less bowel manipulation, less fluid and blood loss, and quicker return of
               bowel function. Larger retrospective series with longer follow up are beginning to emerge, but there remains
               significant heterogeneity in the experience of the teams and surgeons involved, making meaningful
               interpretation of their results challenging. Nevertheless, from higher volume centers, results demonstrate
               the safety and feasibility of RARC with RIN. Perceptively, perioperative and functional outcomes for well-
               selected patients may be superior to ileal conduit and ECUD. However, the results of well-structured studies
               such as the iROC are keenly anticipated and will hopefully shed light on some of these unanswered
               questions.

               DECLARATIONS
               Authors’ contributions
               Performed data analysis, interpretation, and manuscript write up: Maqboul F
               Technical description of operative steps, data acquisition: Dovey Z
               Review of manuscript: Thinagaran JKR
               Review and substantial contributions to conception and design of study: Dovey Z, Wiklund P

               Availability of data and materials
               Not applicable.

               Financial support and sponsorship
               None.


               Conflicts of interest
               Dr. Zach Dovey is Medical Director and stock owner (with certificate of shares) of Medtech Holdings Ltd.


               Ethical approval and consent to participate
               Not applicable.


               Consent for publication
               Not applicable.

               Copyright
               © The Author(s) 2021.


               REFERENCES
               1.       Zamboni S, Soria F, Mathieu R, et al; European Association of Urology - Young Academic Urologists (EAU-YAU); Urothelial
                   carcinoma working group. Differences in trends in the use of robot-assisted and open radical cystectomy and changes over time in
                   peri-operative outcomes among selected centres in North America and Europe: an international multicentre collaboration. BJU Int
                   2019;124:656-64.  DOI  PubMed
               2.       Hussein AA, May PR, Jing Z, et al; Collaborators. Outcomes of intracorporeal urinary diversion after robot-assisted radical
                   cystectomy: results from the international robotic cystectomy consortium. J Urol 2018;199:1302-11.  DOI  PubMed
               3.       Chan KG, Guru K, Wiklund P, et al; Pasadena Consensus Panel. Robot-assisted radical cystectomy and urinary diversion: technical
                   recommendations from the Pasadena Consensus Panel. Eur Urol 2015;67:423-31.  DOI  PubMed
   79   80   81   82   83   84   85   86   87   88   89